Recruitment

Recruitment Status
Completed
Estimated Enrollment
16

Exclusion Criteria

History of exposure to any radiation >15 mSv/year (e.g., occupational or radiation therapy) over the past year.
Clinically significant abnormalities on physical examination, medical history, ECG , vital signs, laboratory values, or unstable medical or psychiatric illness
Pregnant or breast feeding.
...
History of exposure to any radiation >15 mSv/year (e.g., occupational or radiation therapy) over the past year.
Clinically significant abnormalities on physical examination, medical history, ECG , vital signs, laboratory values, or unstable medical or psychiatric illness
Pregnant or breast feeding.
Clinically significant allergy or sensitivity to medications Positive test for human immunodeficiency virus (HIV) antibodies, Hepatitis B surface antigen, or Hepatitis C antibody.
Any disorder that may interfere with drug absorption.

Summary

Conditions
Healthy
Type
Interventional
Phase
Phase 1
Design
  • Allocation: Non-Randomized
  • Intervention Model: Parallel Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Basic Science

Participation Requirements

Age
Between 18 years and 50 years
Gender
Both males and females

Exclusion Criteria

History of exposure to any radiation >15 mSv/year (e.g., occupational or radiation therapy) over the past year.
Clinically significant abnormalities on physical examination, medical history, ECG , vital signs, laboratory values, or unstable medical or psychiatric illness
Pregnant or breast feeding.
...
History of exposure to any radiation >15 mSv/year (e.g., occupational or radiation therapy) over the past year.
Clinically significant abnormalities on physical examination, medical history, ECG , vital signs, laboratory values, or unstable medical or psychiatric illness
Pregnant or breast feeding.
Clinically significant allergy or sensitivity to medications Positive test for human immunodeficiency virus (HIV) antibodies, Hepatitis B surface antigen, or Hepatitis C antibody.
Any disorder that may interfere with drug absorption.

Tracking Information

NCT #
NCT02001389
Collaborators
Not Provided
Investigators
Not Provided